E-test method for detecting antibiotic synergy against Pseudomonas aeruginosa from neutropenic patients: A cost-effective approach

New Microbiologica

Volumn 27, Issue 3, 2004, Pages 263-272

  Di Bonaventura, G ^a   Picciani, C ^a   Spedicato, I ^a   Piccolomini, R ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Checkerboard; Cost analysis; E test; Neutropenic; Pseudomonas aeruginosa; Synergy

Indexed keywords

CEFOTAXIME; CEFTRIAXONE; GREPAFLOXACIN; LEVOFLOXACIN; REAGENT;

ANTIMICROBIAL ACTIVITY; ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG ANTAGONISM; METHODOLOGY; NEUTROPENIA; NONHUMAN; PSEUDOMONAS AERUGINOSA;

ANEMIA; ANTI-BACTERIAL AGENTS; CEFOTAXIME; CEFTRIAXONE; COST-BENEFIT ANALYSIS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FLUOROQUINOLONES; HEMATOLOGIC NEOPLASMS; HUMANS; MICROBIAL SENSITIVITY TESTS; NEUTROPENIA; OFLOXACIN; PIPERAZINES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 11444261874     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. BARRY, A.L., AND FUCHS, P.C. (1997). Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin. Journal of Chemotherapy, 9, 9-16.
2. BLONDEAU, J.M., LASKOWSKI, R., BJARNASON, J., AND STEWART, C. (2000). Comparative in vitro activity of gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin and trovafloxacin against 4151 Gram-negative and Gram-positive organisms. International Journal of Antimicrobial Agents, 14, 45-50.
3. th International Congress of Chemotherapy, Jerusalem.
4. BOLMSTROM, A., KARLSSON, A., NORDSTROM, U., AND MILLS, K. (1995). Etest for drug combination studies with mycobacteria (abstract). International Congress of Chemotherapy, Montreal.
5. BONAPACE, C.R., WHITE, R.L., FRIEDRICH, L.V., AND BOSSO, J.A. (2000). Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods. Diagnostic Microbiology and Infectious Disease, 38, 43-50.
6. CAPPELLETTY, D.M., AND RYBAK, M.J. (1996). Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy, 40, 677-683.
7. CHATZINIKOLAOU, I., ABI-SAID, D., BODEY, G.P., ROLSTON, K.V., TARRAND, J., AND SAMONIS, G. (2000). Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: Retrospective analysis of 245 episodes. Archives of Internal Medicine, 160, 501-509.
8. CUNHA, B.A. (1998). Quinolones: clinical use and formulary considerations. Advances in Therapy, 15, 277-287.
9. DAVIS, R., AND BRYSON, H.M. (1994). Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy. Drugs, 47, 677-700.
10. DI BONAVENTURA, G., RICCI, E., DELLA LOGGIA, N., CATAMO, G., AND PICCOLOMINI, R. (1998). Evaluation of E-test for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from patients with long-term bladder catheterization. Journal of Clinical Microbiology, 36, 824-826.
11. ELIOPOULOS, G.M., WENNERSTEN, C.B., AND MOELLERING, R.C. (1996). Comparative in vitro activity of levofloxacin and ofloxacin against Gram-positive bacteria. Diagnostic Microbiology and Infectious Disease, 25, 35-41.
12. FLYNN, C.M., JOHNSON, D.M., AND JONES, R.N. (1998). In vitro efficacy of levofloxacin alone or in combination tested against multi-resistant Pseudomonas aeruginosa strains. Journal of Antimicrobial Chemotherapy, 8, 411-415.
13. GERCEKER, A.A., AND GURLER, B. (1995). In vitro activities of various antibiotics, alone and in combination with amikacin against Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy, 36, 707-711.
14. GIMENO, C., BORJA, J., NAVARRO, D., VALDÈS, L., GARCÌA-BARBAL, J., AND GARCÌA-DE-LOMAS, J. (1998). In vitro interaction between ofloxacin and cefotaxime against Gram-positive and Gram-negative bacteria involved in serious infections. Chemotherapy, 44, 94-98.
15. GOULD, I.M., AND MILNE, K. (1997). In-vitro pharmacodynamic studies of piperacillin/tazobactam with gentamicin and ciprofloxacin. Journal of Antimicrobial Chemotherapy, 39, 53-61.
16. HEINEMAN, H.S., LOFTON, W.M. (1978). Unpredictable response of Pseudomonas aeruginosa to synergistic antibiotic combinations in vitro. Antimicrobial Agents and Chemotherapy, 13, 827-831.
17. HOFFNER, S.E., KLINTZ, L., OLSSON-LILJEQUIST, B., KARLSSÖN, A., AND BOLMSTROM, A. (1993). Rapid susceptibility testing of Mycobacterium chelonae and M. fortuitum to single and combined drugs using Etest (abstract). International Congress of Chemotherapy, Stockholm.
18. ISEMBERG, H.D., ALPERSTEIN, P., AND FRANCE, K. (1999). In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with beta-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia. Diagnostic Microbiology and Infectious Disease, 33, 81-86.
19. KOLAR, M., LATAL, T., AND HAJEK, V. (1999). Development of bacterial resistance to the third generation cephalosporins and their clinical use. Journal of Chemotherapy, 11, 260-265.
20. LEWIS, R.E., DIEKEMA, D.J., MESSER, S.A., PFALLER, M.A., AND KLEPSER, M.E. (2002). Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between anti-fungal agents tested against Candida species. Journal of Antimicrobial Chemotherapy, 49, 345-351.
21. LUBASCH, A., KELLER, I., BORNER, K., KOEPPE, P., AND LODE, H. (2000). Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteers. Antimicrobial Agents and Chemotherapy, 44, 2600-2603.
22. MACGOWAN, A.P., WOOTTON, M., AND HOLTZ, H.A. (1999). The antibacterial efficacy of levofloxacin and ciprofloxacin against Pseudomonas aeruginosa assessed by combining antibiotic exposure and bacterial susceptibility. Journal of Antimicrobial Chemotherapy, 43, 345-349.
23. MAYER, I., AND NAGY, E. (1999). Investigation of the synergic effects of aminoglycoside-fluoroquinolone and third-generation cephalosporin combinations against clinical isolates of Pseudomonas spp. Journal of Antimicrobial Chemotherapy, 43, 651-657.
24. NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS (2002). Performance standards for antimicrobial susceptibility testing; document M100-S12, 12th informational supplement, NCCLS, 2002.
25. PEREA, S., GONZALEZ, G., FOTHERGILL, A.W., KIRKPATRICK, W.R., RINALDI, M.G., AND PATTERSON, T.F. (2002). In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp. Antimicrobial Agents and Chemotherapy, 46, 3039-3041.
26. PICCOLOMINI, R., DI BONAVENTURA, G., CATAMO, G., CARBONE, F., AND NERI, M. (1997). Comparative evaluation of the E-test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents. Journal of Clinical Microbiology, 35, 1842-1846.
27. PIDDOCK, L.J., JOHNSON, M., RICCI, V., AND HILL, S.L. (1998). Activities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tract. Antimicrobial Agents and Chemotherapy, 42, 2956-2960.
28. POUPARD, J., LANGAN, R., UTRUP, L., RITTENHOUSE, S., AND CLARK, R.B. (1993). Use of the AB BIODISK E-test as a screen for ticarcillin clavulanate (T/C)-amikacin (Ak) synergy with isolates of Xanthomonas maltophilia (abstract). International Congress of Chemotherapy, Stockholm.
29. ROLSTON, K.V., BERKEY, P., BODEY, G.P., ANAISSIE, E.J., KHARDORI, N.M., JOSHI, J.H., KEATING, M.J., HOLMES, F.A., CABANILLAS, F.F., AND ELTING, L. (1992). A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients. Archives of Internal Medicine, 152, 283-291.
30. SEGATORE, B., SETACCI, D., PERILLI, M., FRANCESCHINI, N., MARCHETTI, F., AND AMICOSANTE, G. (2000). Bactericidal activity of levofloxacin and ciprofloxacin on clinical isolates of different phenotypes of Pseudomonas aeruginosa. International Journal of Antimicrobial Agents, 13, 223-226.
31. SOLBERG, O., AND SJURSEN, H. (1995). Safety and efficacy of meropenem in patients with septicaemia: a randomized comparison with ceftazidime, alone or combined with amikacin. Journal of Antimicrobial Chemotherapy, 36 (suppl. A), 157-166.
32. SPENCER, R.C. (1996). An 8 year Microbe Base survey of the epidemiology, frequency and antibiotic susceptibility of Pseudomonas aeruginosa hospital isolates in the United Kingdom. Journal of Antimicrobial Chemotherapy, 37, 251-301.
33. STEVENS, D.L., MADARAS-KELLY, K.J., AND RICHARDS, D.M. (1998). In vitro antimicrobial effects of various combinations of penicilin and clindamycin against four strains of Streptococcus pyogenes. Antimicrobial Agents and Chemotherapy, 42, 1266-1268.
34. SWIATLO, E., MOORE, E., WATT, J., AND MCDANIELS, L.S. (2000). In vitro activity of four fluoroquinolones against clinical isolates of Pseudomonas aeruginosa determined by the E-test. International Journal of Antimicrobial Agents, 15, 73-76.
35. VISALLI, M.A., BAJAKSOUZIAN, S., JACOBS, M.R., AND APPELBAUM, P.C. (1997). Comparative activity of trovafloxacin, alone and in combination with other agents, against Gram-negative nonfermentative rods. Antimicrobial Agents and Chemotherapy, 41, 1475-1481.
36. VISALLI, M.A., JACOBS, M.R., AND APPELBAUM, P.C. (1998). Determination of activities of levofloxacin, alone and combined with gentamicin, ceftazidime, cefpirome, and meropenem, against 124 strains of Pseudomonas aeruginosa by checkerboard and time-kill methodology. Antimicrobial Agents and Chemotherapy, 42, 953-955.
37. VISCOLI, C. (1998). The evolution of the empirical management of fever and neutropenia in cancer patients. Journal of Antimicrobial Chemotherapy, 41 (suppl. D), 65-80.
38. WHITE, R.L., BURGESS, D.S., MANDURU, M., AND BOSSO, J.A. (1996). Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E-test. Antimicrobial Agents and Chemotherapy, 40, 1914-1918.
39. YAMANE, N., JONES, R.N., FREI, R., HOBAN, D.J., PIGNATARI, A.D., AND MARCO, F. (1994). Levofloxacin in vitro activity: results from an international comparative study with ofloxacin and ciprofloxacin. Journal of Chemotherapy, 6, 83-91.